2,545 reports of this reaction
3.2% of all ESTRADIOL TRANSDERMAL reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for ESTRADIOL TRANSDERMAL, manufactured by Amneal Pharmaceuticals NY LLC. There are 2,545 FDA adverse event reports linking ESTRADIOL TRANSDERMAL to HEADACHE. This represents approximately 3.2% of all 79,078 adverse event reports for this drug.
Patients taking ESTRADIOL TRANSDERMAL who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ESTRADIOL TRANSDERMAL users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ESTRADIOL TRANSDERMAL:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 2,545 FDA reports for ESTRADIOL TRANSDERMAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for ESTRADIOL TRANSDERMAL, making it a notable side effect.
If you experience headache while taking ESTRADIOL TRANSDERMAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.